BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30612740)

  • 21. METTL13 promotes nasopharyngeal carcinoma progression through regulating the ZEB1/TPT1 axis.
    Ni H; Liang C; Zhou Z; Jiang B; Li Y; Shang H; Yu X
    J Gene Med; 2023 May; 25(5):e3476. PubMed ID: 36735630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mettl13 protects against cardiac contractile dysfunction by negatively regulating C-Cbl-mediated ubiquitination of SERCA2a in ischemic heart failure.
    Yu S; Sun Z; Wang X; Ju T; Wang C; Liu Y; Qu Z; Liu K; Mei Z; Li N; Lu M; Wu F; Huang M; Pang X; Jia Y; Li Y; Zhang Y; Dou S; Jiang J; Li X; Yang B; Du W
    Sci China Life Sci; 2023 Dec; 66(12):2786-2804. PubMed ID: 37450238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-directed mutants of post-translationally modified sites of yeast eEF1A using a shuttle vector containing a chromogenic switch.
    Cavallius J; Popkie AP; Merrick WC
    Biochim Biophys Acta; 1997 Feb; 1350(3):345-58. PubMed ID: 9061031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of eukaryotic elongation factor 1 alpha (eEF1A) by dynamic lysine methylation.
    Jakobsson ME; Małecki J; Falnes PØ
    RNA Biol; 2018 Mar; 15(3):314-319. PubMed ID: 29447067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.
    Treekitkarnmongkol W; Solis LM; Sankaran D; Gagea M; Singh PK; Mistry R; Nguyen T; Kai K; Liu J; Sasai K; Jitsumori Y; Liu J; Nagao N; Stossi F; Mancini MA; Wistuba II; Thompson AM; Lee JM; Cadiñanos J; Wong KK; Abbott CM; Sahin AA; Liu S; Katayama H; Sen S
    Sci Signal; 2024 Mar; 17(826):eadh4475. PubMed ID: 38442201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein Methylation and Translation: Role of Lysine Modification on the Function of Yeast Elongation Factor 1A.
    White JT; Cato T; Deramchi N; Gabunilas J; Roy KR; Wang C; Chanfreau GF; Clarke SG
    Biochemistry; 2019 Dec; 58(49):4997-5010. PubMed ID: 31738538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of Elongation Factor 1A: Where, Who, and Why?
    Hamey JJ; Wilkins MR
    Trends Biochem Sci; 2018 Mar; 43(3):211-223. PubMed ID: 29398204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of METTL14 mediates the elevation of PERP mRNA N
    Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
    Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis.
    Carrer A; Trefely S; Zhao S; Campbell SL; Norgard RJ; Schultz KC; Sidoli S; Parris JLD; Affronti HC; Sivanand S; Egolf S; Sela Y; Trizzino M; Gardini A; Garcia BA; Snyder NW; Stanger BZ; Wellen KE
    Cancer Discov; 2019 Mar; 9(3):416-435. PubMed ID: 30626590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.
    Colón-Bolea P; Crespo P
    Bioessays; 2014 Dec; 36(12):1162-9. PubMed ID: 25382779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifier variant of METTL13 suppresses human GAB1-associated profound deafness.
    Yousaf R; Ahmed ZM; Giese AP; Morell RJ; Lagziel A; Dabdoub A; Wilcox ER; Riazuddin S; Friedman TB; Riazuddin S
    J Clin Invest; 2018 Apr; 128(4):1509-1522. PubMed ID: 29408807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein glutaminylation is a yeast-specific posttranslational modification of elongation factor 1A.
    Jank T; Belyi Y; Wirth C; Rospert S; Hu Z; Dengjel J; Tzivelekidis T; Andersen GR; Hunte C; Schlosser A; Aktories K
    J Biol Chem; 2017 Sep; 292(39):16014-16023. PubMed ID: 28801462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT2 deletion enhances KRAS-induced tumorigenesis in vivo by regulating K147 acetylation status.
    Song HY; Biancucci M; Kang HJ; O'Callaghan C; Park SH; Principe DR; Jiang H; Yan Y; Satchell KF; Raparia K; Gius D; Vassilopoulos A
    Oncotarget; 2016 Dec; 7(49):80336-80349. PubMed ID: 27637077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia.
    Ray KC; Moss ME; Franklin JL; Weaver CJ; Higginbotham J; Song Y; Revetta FL; Blaine SA; Bridges LR; Guess KE; Coffey RJ; Crawford HC; Washington MK; Means AL
    Oncogene; 2014 Feb; 33(7):823-31. PubMed ID: 23376846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel post-translational modification of yeast elongation factor 1A. Methylesterification at the C terminus.
    Zobel-Thropp P; Yang MC; Machado L; Clarke S
    J Biol Chem; 2000 Nov; 275(47):37150-8. PubMed ID: 10973948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The eEF1A protein in cancer: Clinical significance, oncogenic mechanisms, and targeted therapeutic strategies.
    Zhang W; Wang J; Shan C
    Pharmacol Res; 2024 Jun; 204():107195. PubMed ID: 38677532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis reveals potential phosphorylation sites in eukaryotic elongation factor 1A that are important for its activity.
    Mateyak MK; He D; Sharma P; Kinzy TG
    FEBS Lett; 2021 Sep; 595(17):2208-2220. PubMed ID: 34293820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.
    Wang Z; Hausmann S; Lyu R; Li TM; Lofgren SM; Flores NM; Fuentes ME; Caporicci M; Yang Z; Meiners MJ; Cheek MA; Howard SA; Zhang L; Elias JE; Kim MP; Maitra A; Wang H; Bassik MC; Keogh MC; Sage J; Gozani O; Mazur PK
    Cancer Cell; 2020 Jun; 37(6):834-849.e13. PubMed ID: 32442403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysine methylation signaling in pancreatic cancer.
    Roth GS; Casanova AG; Lemonnier N; Reynoird N
    Curr Opin Oncol; 2018 Jan; 30(1):30-37. PubMed ID: 29076964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.